#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary neuropathic amyloidosis Myelin oligodendrocyte glycoprotein antibody-associated disease Bronchopulmonary aspergillosis Synovitis Ovarian epithelial cancer Ewing's sarcoma recurrent Ischaemic stroke Immunodeficiency congenital Paraneoplastic neurological syndrome Infantile apnoea Immunodeficiency Osteogenesis imperfecta Fusarium infection Thrombotic thrombocytopenic purpura Iron overload More trials…

    Learn about Rare Diseases

    Hepatoblastoma – Treatment Osteosarcoma – Treatment Ornithine transcarbamoylase deficiency – Treatment Mucopolysaccharidosis III – Treatment Ewing’s sarcoma – Treatment Fragile X syndrome – Trials in Disease Hereditary motor and sensory neuropathy – Treatment Lymphatic malformation – Basic Information Toxic epidermal necrolysis – Basic Information Hypereosinophilic syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vericiguat Ulipristal Acetate O15-Water Bendamustine ADCE-D01 Dexamfetamine Sulfate Emraclidine Digitoxin Melphalan Flufenamide KETOROLAC Livmoniplimab Ivermectin Alectinib F510/08 GRNA-001 Lecanemab Alnus Glutinosa Pollen Cimetidine Hydrochloride Topotecan Hydrochloride [18F]CPFPX More therapies…

    Learn about Your Condition

    Essential hypertension ROHHAD syndrome Patent ductus arteriosus Oesophageal achalasia Arteriospasm coronary Prader-Willi syndrome Brain stem glioma Type 2 diabetes mellitus Netherton's syndrome Fatty acid oxidation disorder Fallopian tube cancer stage IV Spinal osteoarthritis Mitral valve incompetence Hepatitis D Labour induction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Sickle cell anaemia with crisis

  • Comparing morphine alone to morphine and lidocaine for pain relief in sickle cell anemia patients with vaso-occlusive crisis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Morphine Hydrochloride
    • Lidocaine Hydrochloride
    Belgium

  • Study of Intranasal Sufentanil and Intravenous Morphine for Severe Sickle Cell Pain Crisis in Children

    Recruiting

    3 1 1
    Investigated Diseases:
    • Sickle cell anaemia with crisis
    Investigated Drugs:
    • Sufentanil
    • Morphine Hydrochloride
    • Sodium Chloride
    France

  • Study of the effectiveness of iloprost compared to a placebo for treating vaso-occlusive crises in adults with sickle cell disease

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    • Sickle cell anaemia with crisis
    Investigated Drugs:
    • ILOPROST
    • Glucose Monohydrate
    France

  • Study on the Safety and Effectiveness of CSL889 for Adults and Adolescents with Sickle Cell Disease During Painful Crises

    Not recruiting

    4 1
    Investigated Diseases:
    • Sickle cell anaemia with crisis
    Investigated Drugs:
    • HEMOPEXIN, HUMAN
    Belgium France Germany Greece Italy The Netherlands +1

  • Study on Crovalimab for Preventing Painful Episodes in Sickle Cell Disease Patients

    Not recruiting

    2 1
    Investigated Diseases:
    • Sickle cell anaemia with crisis
    • Sickle cell disease
    France Italy The Netherlands Spain

  • Study on the Safety and Effects of Crovalimab for Treating Vaso-Occlusive Episodes in Sickle Cell Disease Patients

    Not recruiting

    1 1
    Investigated Diseases:
    • Sickle cell anaemia with crisis
    • Sickle cell disease
    Investigated Drugs:
    • Crovalimab
    France Italy The Netherlands Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!